Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH | NASDAQ

$2.45

+$0.04 (+1.66%)

At close: Sep 21, 2026, 4:00 PM ET

$2.40

-$0.05 (-2.04%)

Pre-market: Sep 22, 2026, 8:05 AM ET

Fiscal Year Period Ending	FY 2025 Oct 30, 2025	FY 2024 Oct 30, 2024	FY 2023 Oct 30, 2023	FY 2022 Oct 30, 2022	FY 2021 Oct 30, 2021
Revenue	2.52M	2.38M	2.46M	1.92M	931.04K
Cost of Revenue	142.53K	195.34K	310.99K	509.16K	311.16K
Gross Profit	2.38M	2.19M	2.15M	1.41M	619.87K
Operating Income	-24.15M	793.71K	1.18M	197.02K	-500.98K
Interest Income	6.1K	783	1.59K	263	167
Pretax Income	-24.08M	793.42K	1.18M	190.01K	-484.96K
Net Income	-24.36M	478.56K	852.04K	191.3K	-484.96K
Selling & General & Admin	26.11M	1.18M	784.57K	1.15M	1.12M
Research & Development	238.18K	36.71K	30.88K	60.67K	52.01K
Other Expenses	184.2K	179.9K	152.11K	6.44K	-52.01K
Operating Expenses	26.53M	1.39M	967.56K	1.21M	1.12M
Interest Expense	41	n/a	n/a	194	1.19K
Selling & Marketing Expenses	625.29K	361.33K	299.62K	438.6K	369.03K
Cost & Expenses	26.67M	1.59M	1.28M	1.72M	1.43M
Income Tax Expense	280.65K	314.86K	329.53K	-1.29K	n/a
Shares Outstanding (Basic)	588.87K	524K	524K	524K	524K
Shares Outstanding (Diluted)	588.87K	524K	524K	524K	524K
EPS (Basic)	-41.38	0.92	1.63	0.36	-0.93
EPS (Diluted)	-41.38	0.92	1.63	0.36	-0.93
EBITDA	-23.97M	816.11K	1.2M	220.7K	-444.76K
EBIT	-24.08M	793.42K	1.18M	190.2K	-483.76K
Depreciation & Amortization	109.37K	22.69K	20.06K	30.49K	39.01K